不可切除结直肠肝转移肝移植术前18F-FDG PET/CT的预后价值
该回顾性研究评估了SECA研究中23例不可切除结直肠肝转移患者肝移植术前18F-FDG PET/CT的体积及代谢参数的预后价值。总MTV和TLG低于截断值与3年和5年OS及DFS改善显著相关,而SUVmax、SUVmean、SUVpeak及T/B比值与生存无显著相关。总MTV和TLG可能有助于改善肝移植患者选择。
要点
- 总MTV和TLG低于截断值与3年、5年OS改善显著相关(P=0.027和0.026)。
- 总MTV和TLG低于截断值与DFS改善显著相关(P=0.01)。
- SUVmax、SUVmean、SUVpeak及T/B比值与1年、3年、5年OS和DFS无显著相关。
核心结论
- 肝移植术前18F-FDG PET/CT测得的总MTV和TLG与不可切除结直肠肝转移患者移植后3年和5年OS及DFS改善显著相关,并可能改善肝移植的患者选择。
研究设计与样本
- 回顾性评估SECA(继发性癌症)研究中所有接受肝移植患者的术前18F-FDG PET/CT检查,共23例患者接受肝移植。
- 对全部肝转移灶测量并计算SUVmax、SUVmean、SUVpeak、肿瘤与本底比值(T/B)、代谢肿瘤体积(MTV)和总病灶糖酵解(TLG),并计算每例患者的总MTV和TLG。
- 采用受试者工作特征(ROC)分析确定各参数的截断值并将患者分为两组,采用Kaplan-Meier法和log rank检验比较截断值上下患者的1年、3年和5年总生存(OS)和无病生存(DFS)。
主要发现
- 总MTV和TLG低于截断值与3年和5年OS改善显著相关(P=0.027和P=0.026)。
- 总MTV和TLG低于截断值与DFS改善显著相关(P=0.01)。
- 1年、3年和5年OS和DFS与SUVmax、SUVmean、SUVpeak或T/B比值无显著相关。
关键数值与推荐
- 总MTV和TLG低于截断值与3年OS改善显著相关(P=0.027)。
- 总MTV和TLG低于截断值与5年OS改善显著相关(P=0.026)。
- 总MTV和TLG低于截断值与DFS改善显著相关(P=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The main objective of this study was to evaluate the prognostic value of volumetric and metabolic information derivied from F-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) in combination with computed tomography (CT) prior to liver transplantation (LT) in patients with nonresectable colorectal liver metastases (CLM). Due to scarcity of liver grafts, prognostic information enabling selection of candidates who will gain the highest survival after LT is of vital importance. 18F-FDG PET/CT was a part of the preoperative study protocol. Patients without evidence of extrahepatic malignant disease on 18F-FDG PET/CT who also fulfilled all the other inclusion criteria underwent LT. METHODS: The preoperative 18F-FDG PET/CT examinations of all patients included in the SECA (secondary cancer) study were retrospectively assessed. Maximum, mean and peak standardized uptake values (SUVmax, SUVmean and SUVpeak), tumor to background (T/B) ratio, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured and calculated for all liver metastases. Total MTV and TLG were calculated for each patient. Cut-off values were determined for each of these parameters by using receiver operating characteristic (ROC) analysis dividing the patients into two groups. One, three and five-year overall survival (OS) and disease free survival (DFS) for patients over and under the cut-off value were compared by using the Kaplan-Meier method and log rank test. RESULTS: Twenty-three patients underwent LT in the SECA study. Total MTV and TLG under the cut-off values were significantly correlated to improved OS at three and five years (p = 0.027 and 0.026) and DFS (p = 0.01). One, three and five-year OS and DFS were not significantly related to SUVmax, SUVmean, SUVpeak or T/B-ratio. CONCLUSION: Total MTV and TLG from 18F FDG PET/CT prior to LT for nonresectable CLM were significantly correlated to improved three and five-year OS and DFS and can potentially improve the patient selection for LT.
引用
- Grut H, Dueland S, Line PD, et al. The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases. Eur J Nucl Med Mol Imaging. 2017. PMID: 29026950. doi:10.1007/s00259-017-3843-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。